Proxy Votes Now

Home › Activist investors › 22NW

22NW

Campaign activist. Positions and campaigns from 22NW’s SEC filings. Updated November 20, 2026.

Filer entities
22NW, LP
SEC CIK
1694297 (22NW, LP)
SEC filings
Schedule 13D filings · 13F reports · soliciting material
Latest 13F
Quarter ended Sep 30, 2026, filed Nov 13, 2026: 15 US-listed positions reported; 7 of 1% or more of a company without a 13D are listed below.
10current positions
3new or changed in 90 days
0active campaigns
6campaigns on record

Active campaigns

No active campaign by this definition (see How to read this).

Current positions (10)

CompanyStakeSourceFirst disclosedLast changeSince previous filingFlagsStated intent
Turtle Beach Corporation 7.27%1,304,878 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Oct 29, 2026 Aug 14, 2026 Increased Nov 13, 2026 ▲ 7.19 pts Increased 13F: none stated
Core Molding Technologies, Inc. 3.91%345,291 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Nov 2, 2026 Aug 14, 2025 Increased Nov 13, 2026 ▲ 0.81 pts Increased 13F: none stated
Aebi Schmidt Holding AG 1.61%1,245,240 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Mar 31, 2026 Nov 13, 2026 — — New 13F: none stated
Culp Inc 14.7%1,859,061 shares Schedule 13D/A, filed Dec 12, 2025 Apr 12, 2024 Increased Jun 9, 2025 ▼ 0.10 pts — Seeks changes or engagement
Stoneridge Inc 8.2%2,297,092 shares Schedule 13D/A, filed Feb 27, 2026 Feb 6, 2026 — 0.00 pts — Seeks changes or engagement
Lifecore Biomedical, Inc. 6.7%2,712,472 shares Schedule 13D/A, filed Jul 2, 2026 Jun 28, 2023 Decreased Jul 2, 2026 ▼ 0.75 pts — Standard Item 4 language
Unifi, Inc. 4.57%849,955 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Oct 30, 2026 Feb 14, 2025 — ▼ 0.01 pts — 13F: none stated
Team, Inc. 3.71%170,187 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Aug 6, 2026 Feb 14, 2017 — 0.00 pts — 13F: none stated
Fox Factory Holding Corp. 1.62%678,165 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Apr 3, 2026 May 15, 2026 — 0.00 pts — 13F: none stated
Insperity, Inc. 1.29%493,000 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Oct 22, 2026 May 15, 2020 — 0.00 pts — 13F: none stated

Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.

Stated intent (13D Item 4)

Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.

Culp Inc · Seeks changes or engagement

“Item 4 is hereby amended to add the following: On June 6, 2025, the Reporting Persons entered into a cooperation agreement (the "2025 Cooperation Agreement") with the Issuer pursuant to which, among other things, the Issuer agreed (i) to nominate Alexander B. Jones, Doug Collier and Lynn Heatherton for election to the Issuer's board of directors (the "Board") at the Issuer's 2025 Annual Meeting of”

Item 4 in the Schedule 13D/A filed Dec 12, 2025; this amendment did not restate Item 4, so the text is from the filing of Jun 9, 2025.

Stoneridge Inc · Seeks changes or engagement

“Item 4 is hereby amended to add the following: On February 26, 2026, the Reporting Persons entered into a cooperation agreement (the "Cooperation Agreement") with the Issuer. Pursuant to the Cooperation Agreement, the Issuer agreed to increase the size of the Issuer's board of directors (the "Board") from seven (7) to eight (8) directors and to appoint Aron R. English to the Board to fill the resulting”

Item 4 in the Schedule 13D/A filed Feb 27, 2026.

Lifecore Biomedical, Inc. · Standard Item 4 language

“Item 4 is hereby amended to add the following: The Reporting Persons are holders of shares of Series A Convertible Preferred Stock, par value $0.001 per share (the "Series A Preferred Stock"), of the Issuer, with rights as provided in the Certificate of Designations, Preferences, and Rights of Series A Convertible Preferred Stock of the Issuer (the "Certificate of Designations"). Section 8 of the”

Item 4 in the Schedule 13D/A filed Jul 2, 2026.

Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.

Past campaigns (6)
CompanyOutcome or last statusDateFirst filingHighest stageFilingsMeeting / votes
Farmer Brothers CoBoard seats Stake reported below 5% May 7, 2026 Oct 16, 2023 Nominations made latest (4) —
Foster L B Co Stake reported below 5% Apr 21, 2026 Jan 26, 2024 — latest (2) —
Stoneridge Inc Settled (agreement with the company) Feb 27, 2026 Feb 6, 2026 — latest (2) —
Culp Inc Settled (agreement with the company) Jun 18, 2024 Apr 12, 2024 — latest (3) —
Lifecore Biomedical, Inc.Board seats Settled (agreement with the company) Jul 1, 2024 May 20, 2024 Nominations made latest (2) —
Dirtt Environmental Solutions LTD Settled (agreement with the company) Mar 26, 2024 Mar 26, 2024 — latest (1) —
Past positions (3)
CompanyLast stakeSourceOutcomeDate
Dirtt Environmental Solutions LTD 30.3% Schedule 13D/A, filed Feb 18, 2026 Not in the 13F for the quarter ended Mar 31, 2026 May 15, 2026
Farmer Brothers Co 0.0% Schedule 13D/A, filed May 7, 2026 Exited May 7, 2026
Foster L B Co 2.5% Schedule 13D/A, filed Apr 21, 2026 Reported below 5% in a 13D/A Apr 21, 2026

How large managers voted in 22NW’s proxy contests (meetings since July 2023)

Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.

No proxy contest has gone to a vote since July 1, 2023.

Track record

How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.

6Settlement
Outcome of each campaign (6)
CompanyOutcomeDetailDateFirst filing
Farmer Brothers Co Settlement agreement with the company Aug 16, 2024 Oct 16, 2023
Foster L B Co Settlement agreement with the company Jan 26, 2024 Jan 26, 2024
Stoneridge Inc Settlement agreement with the company Feb 27, 2026 Feb 6, 2026
Culp Inc Settlement agreement with the company Jun 9, 2025 Apr 12, 2024
Lifecore Biomedical, Inc. Settlement agreement with the company Jul 1, 2024 May 20, 2024
Dirtt Environmental Solutions LTD Settlement agreement with the company Mar 26, 2024 Mar 26, 2024

Share price after the first 13D

The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 1 of 6 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).

CompanyFirst 13DTo latest closeSPY same dates6 months after12 months after
Stoneridge Inc SRI Feb 6, 2026 -40.9%Feb 6, 2026 – Nov 18, 2026 +5.7% -11.9%SPY +12.0% not yet / no price

Prices: daily closes (Nasdaq), as stored by the site.

Other disclosed holders around the same time

Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of 22NW’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.

Turtle Beach Corporation · 22NW first disclosed Aug 14, 2026 · 4 other filings
HolderFormDateStake
Hoak Public Equities, LP Schedule 13D Feb 24, 2026 5.2%
Morgan Stanley Schedule 13G May 12, 2026 5.9%
Albert Rabil Schedule 13G May 28, 2026 7.2%
22NW Fund, LP Schedule 13G Sep 2, 2026 7.3%
Fox Factory Holding Corp. · 22NW first disclosed May 15, 2026 · 6 other filings
HolderFormDateStake
RWWM, Inc. Schedule 13G Dec 4, 2025 10.6%
The Vanguard Group Schedule 13G Jan 30, 2026 9.2%
Nantahala Capital Management, LLC Schedule 13G Feb 13, 2026 5.2%
Engine Capital 13F Feb 17, 2026 5.0%
Vanguard Capital Management Schedule 13G Apr 29, 2026 5.1%
Coliseum Capital 13F Aug 14, 2026 3.8%
Stoneridge Inc · 22NW first disclosed Feb 6, 2026 · 4 other filings
HolderFormDateStake
22NW Fund, LP Schedule 13G Aug 13, 2025 7.0%
Dimensional Fund Advisors LP Schedule 13G Oct 9, 2025 4.8%
Royce & Associates LP Schedule 13G Oct 22, 2025 3.7%
BlackRock, Inc. Schedule 13G Jul 30, 2026 7.0%
Core Molding Technologies, Inc. · 22NW first disclosed Aug 14, 2025 · 2 other filings
HolderFormDateStake
The Vanguard Group Schedule 13G Jul 29, 2025 5.1%
Tieton Capital Management, LLC Schedule 13G Nov 12, 2025 5.0%
Foster L B Co · 22NW first disclosed Jan 26, 2024 · 1 other filing
HolderFormDateStake
GAMCO / Gabelli Schedule 13D Aug 9, 2023 —
Lifecore Biomedical, Inc. · 22NW first disclosed Jun 28, 2023 · 1 other filing
HolderFormDateStake
Cove Street Capital Schedule 13D Aug 15, 2023 5.2%
Farmer Brothers Co · 22NW first disclosed Jun 28, 2023 · 1 other filing
HolderFormDateStake
JCP Investment Schedule 13D Oct 16, 2023 4.7%

How to read this

Flags (last 90 days)
New first disclosed in the last 90 days. Increased / Decreased shares up or down in a 13D/A or 13F filed in that time. Below 5% a 13D/A reported less than 5%, the reporting threshold. Exited a 13D/A reported no shares, or the investor’s 13F no longer lists a company it listed before.
Active campaign
A contested meeting at which the investor is soliciting proxies is still to be held; or in the last 12 months it filed a proxy-contest document (PREC14A, DEFC14A or DFAN14A soliciting material), stated in a 13D that it nominated directors, filed a letter or presentation to the board or shareholders, or stated public demands in a 13D — and no settlement, withdrawal, contested vote or 13D below 5% is dated on or after the latest such filing. Status is the furthest step since then: Public demands in a 13D < Public letter or soliciting material < Nominations made < Proxy contest filed.
Sources and limits
SEC EDGAR only. 13D data covers filings since June 2023; 13F reports are quarterly and filed up to 45 days after the quarter, and do not show swaps, most options or non-US holdings. Settlements are cooperation agreements disclosed in the company’s 8-K or stated in the investor’s 13D; board seats are read from the 8-K. Text marked Summary of the filing is checked against the filing, whose words are quoted beside it. Nothing on this page predicts what the investor will do.